-
EP1626697
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1626697
| EP1626697 - PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION COMPRISING LITHIUM CARBONATE [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.01.2011 Database last updated on 24.07.2024 | Most recent event Tooltip | 28.01.2011 | Application deemed to be withdrawn | published on 02.03.2011 [2011/09] | Applicant(s) | For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House, Berkeley Avenue Greenford, Middlesex UB6 0NN / GB | [N/P] |
| Former [2006/08] | For all designated states GLAXO GROUP LIMITED Glaxo Wellcome House Berkeley Avenue Greenford, Middlesex UB6 ONN / GB | Inventor(s) | 01 /
ABNEY, Christopher, Charles 1209 New Log Lick Road Winchester, Kentucky 40391 / US | 02 /
HAMPTON, Brandeon, Scott 10 Sylvania Avenue Winchester, Kentucky 40391 / US | 03 /
NORTON, James, Russell 3587 Briarpatch Way Lexington, Kentucky 40509 / US | 04 /
SCHAVE, Daniel, Joseph 255 Hibiscus Lane Winchester, Kentucky 40391 / US | 05 /
TOMAICH, George, Ronald 3313 Bridlington Road Lexington, Kentucky 40509 / US | [2006/08] | Representative(s) | Giddings, Peter John GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2006/08] | Giddings, Peter John GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | Application number, filing date | 04753033.2 | 20.05.2004 | [2006/08] | WO2004US16135 | Priority number, date | US20030474096P | 29.05.2003 Original published format: US 474096 P | US20030619766 | 15.07.2003 Original published format: US 619766 | [2006/08] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004105691 | Date: | 09.12.2004 | Language: | EN | [2004/50] | Type: | A2 Application without search report | No.: | EP1626697 | Date: | 22.02.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 09.12.2004 takes the place of the publication of the European patent application. | [2006/08] | Search report(s) | International search report - published on: | US | 05.01.2006 | (Supplementary) European search report - dispatched on: | EP | 11.05.2010 | Classification | IPC: | A61K33/00, A61K9/20, A61K47/00, A61P25/18, A61P25/24 | [2006/30] | CPC: |
A61K33/00 (EP,US);
A61P25/18 (EP);
A61P25/24 (EP)
|
| Former IPC [2006/08] | A61K6/00 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/08] | Extension states | AL | Not yet paid | HR | 18.11.2005 | LT | 18.11.2005 | LV | 18.11.2005 | MK | Not yet paid | Title | German: | PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ZUR ORALEN VERABREICHUNG MIT LITHIUMCARBONAT | [2006/08] | English: | PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION COMPRISING LITHIUM CARBONATE | [2006/08] | French: | COMPOSITIONS PHARMACEUTIQUES POUR ADMINISTRATION PAR VOIE ORALE, COMPRENANT DU CARBONATE DE LITHIUM | [2006/08] | Entry into regional phase | 18.11.2005 | National basic fee paid | 18.11.2005 | Search fee paid | 18.11.2005 | Designation fee(s) paid | 18.11.2005 | Examination fee paid | Examination procedure | 18.11.2005 | Examination requested [2006/08] | 21.08.2010 | Application deemed to be withdrawn, date of legal effect [2011/09] | 01.10.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2011/09] | Fees paid | Renewal fee | 27.03.2006 | Renewal fee patent year 03 | 07.05.2007 | Renewal fee patent year 04 | 18.04.2008 | Renewal fee patent year 05 | 07.05.2009 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.05.2010 | 07 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP0471100 (MUEDERRISOGLU ALI [TR], et al) [A] 1-60* claim - *; | [XY]WO0211740 (UNIHART CORP [IE], et al) [X] 1-7,24,37-39,46-48 * page 3, paragraph 1 * [Y] 1-60; | [XY] - ARANCIBIA A ET AL, "Absorption and disposition kinetics of lithium carbonate following administration of conventional and controlled release formulations", INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY, THERAPY ANDTOXICOLOGY, DUSTRI- VERLAG FEISTLE, DEISENHOFEN/MUENCHEN, DE, (19860501), vol. 24, no. 5, ISSN 0174-4879, pages 240 - 245, XP009132950 [X] 36,49,59 * page 241, paragraph 4 - column l * [Y] 1-60 | International search | [X]US4572833 (PEDERSEN ARNE M [DK], et al); | [X]US6365196 (VENKATESH GOPADI M [US], et al); | [Y] - CHOWHAN ET AL, MEDLINE, Database accession no. (NLM3735097), XP008099849 | [ ] - J PHARM SCI., (198606), vol. 75, no. 6, pages 542 - 545 | [Y] - GENNARO ET AL, Pharmaceutical Science., REMINGTON'S PHARMACEUTICAL SCIENCE., (1985), XP002929702 |